Scientists present an overview and perspectives of the SARS‐CoV‐2 induced inflammatory dysfunction and the potential of MSC immunomodulation for the prevention and treatment of COVID‐19 related pulmonary disease.
[Stem Cells]
Sorry, but the selected Zotpress account can't be found.